Diamond Hill Capital Comments on Forest Laboratories Inc

Author's Avatar
Jun 26, 2014

We closed our position in drug manufacturer Forest Laboratories, Inc. (FRX) as the market reacted positively to the news that Actavis, Inc. PLC would buy Forest Laboratories at a significant premium, and the share price approached our estimate of intrinsic value.

From Diamond Hill Capital's Select Fund Commentary – First Quarter 2014.